Olumiant (baricitinib)
pCPA File Number:
22859
Negotiation Status:
Under consideration for negotiation
Indication(s):
Alopecia areata, severe
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CDA-AMC Project Number:
SR0843-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable